Open Insider Trading Activity for Tango Therapeutics, Inc. President, R&D Crystal Adam
31-day price and insider activity (up to 2 years)
Daily candles with triangles for the buy and sale transactions shown below. Scroll left or zoom out to load earlier candles (up to 2 years).
▲ Insider buy
▼ Insider sale
Loading daily price history…
Charting by TradingView Lightweight Charts
| Ticker | Filing Date | Transaction Date | Company | Insider | Title | Transaction | Trade Count | Shares | Avg. Price | Total Value | Position Size Change | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10b5-1: Scheduled Form 4 Transaction TNGX | 2026-10-05 | 2026-10-01 | Tango Therapeutics, Inc. | Crystal Adam | President, R&D | Sell | 2 | 27,000 | $24.47 | $660,796.08 | 18.92% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction TNGX | 2026-04-16 | 2026-04-15 | Tango Therapeutics, Inc. | Crystal Adam | President, R&D | Sell | 1 | 38,460 | $25.00 | $961,500.00 | 25.46% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction TNGX | 2026-04-02 | 2026-04-01 | Tango Therapeutics, Inc. | Crystal Adam | President, R&D | Sell | 1 | 27,000 | $21.20 | $572,400.00 | 19.34% | View Filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting TNGX | 2026-02-04 | 2026-02-03 | Tango Therapeutics, Inc. | Crystal Adam | President, R&D | Sell | 2 | 18,452 | $12.27 | $226,350.16 | 4.69% | View Filing |